We are live on ! Find out more
CA

Clearstead Advisors Portfolio holdings

AUM $10.6B
1-Year Est. Return 24.87%
This Fund
S&P 500
This Quarter Est. Return
+2.37%
1 Year Est. Return
+24.87%
3 Year Est. Return
+71.42%
5 Year Est. Return
+80.33%
10 Year Est. Return
AUM
$7.93B
AUM Growth
+$314M
Cap. Flow
+$948M
Cap. Flow %
11.95%
Top 10 Hldgs %
31.01%
Holding
3,334
New
245
Increased
1,176
Reduced
923
Closed
594

Sector Composition

Rank Sector Weight
1 Technology 12.05%
2 Financials 6.74%
3 Industrials 4.89%
4 Healthcare 3.63%
5 Consumer Discretionary 3.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAPS
2726
DELISTED
WM TECHNOLOGY INC A
MAPS
$4 ﹤0.01%
4
-236
-98% -$232
GME.WS
2727
GameStop Corp Warrants
GME.WS
$4 ﹤0.01%
+1
New +$3
CGC
2728
Canopy Growth
CGC
$410M
$3 ﹤0.01%
2
JELD icon
2729
JELD-WEN Holding
JELD
$164M
$3 ﹤0.01%
1
-300
-100% -$985
JTAI icon
2730
Jet.AI
JTAI
$2.77M
0
UIS icon
2731
Unisys
UIS
$217M
$3 ﹤0.01%
1
-66
-99% -$206
KLTR icon
2732
Kaltura
KLTR
$267M
$2 ﹤0.01%
1
AQB icon
2733
AquaBounty Technologies
AQB
$6.02M
$1 ﹤0.01%
1
ABX
2734
Abacus Global Management
ABX
$913M
-32
Closed -$184
ABR icon
2735
Arbor Realty Trust
ABR
$998M
-10,910
Closed -$133K
ACEL icon
2736
Accel Entertainment
ACEL
$987M
-219
Closed -$2.42K
ACMR icon
2737
ACM Research
ACMR
$5.79B
-1
Closed -$40
ACRS icon
2738
Aclaris Therapeutics
ACRS
$869M
-1
Closed -$2
ACT icon
2739
Enact Holdings
ACT
$6.73B
-309
Closed -$11.8K
ADCT icon
2740
ADC Therapeutics
ADCT
$144M
-1
Closed -$4
ADNT icon
2741
Adient
ADNT
$1.5B
-628
Closed -$15.1K
ADTN icon
2742
Adtran
ADTN
$616M
-30
Closed -$282
ADV icon
2743
Advantage Solutions
ADV
$361M
-6
Closed -$241
AFCG
2744
AFC Gamma
AFCG
$63.4M
-1
Closed -$4
AGIO icon
2745
Agios Pharmaceuticals
AGIO
$1.93B
-291
Closed -$11.7K
AHCO icon
2746
AdaptHealth
AHCO
$759M
-134
Closed -$1.2K
AIN icon
2747
Albany International
AIN
$1.78B
-49
Closed -$2.61K
AIV
2748
Aimco
AIV
$383M
-123
Closed -$976
AKBA icon
2749
Akebia Therapeutics
AKBA
$252M
-838
Closed -$2.29K
AKRO
2750
DELISTED
Akero Therapeutics
AKRO
-26
Closed -$1.24K

Similar funds

Clearstead Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Clearstead Advisors held 3,334 positions worth $7.93B, up 4.1% from $7.62B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Clearstead Advisors deployed $948M of net new capital in Q4 2025, opening 245 new positions and adding to 1,176 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 1,170,336 shares worth $734M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Invesco BulletShares 2027 Corporate Bond ETF, an estimated $29.8M trimmed.

  • Clearstead Advisors's largest Q4 2025 buy was Vanguard S&P 500 ETF: 1,170,336 shares worth $734M.
  • Clearstead Advisors added most to Invesco BulletShares 2033 Corporate Bond ETF in Q4 2025, an estimated $32.2M increase.
  • Clearstead Advisors's biggest Q4 2025 reduction was Invesco BulletShares 2027 Corporate Bond ETF, cutting an estimated $29.8M.
  • Clearstead Advisors fully exited Kellanova in Q4 2025, selling an estimated $2.05M.
  • Clearstead Advisors's ten largest holdings make up 31% of its $7.93B portfolio in Q4 2025.
  • Clearstead Advisors opened 245 new positions and closed 594 in Q4 2025.
  • Clearstead Advisors's portfolio value rose 4.1% quarter-over-quarter to $7.93B.

Based on Clearstead Advisors's 13F filing for Q4 2025, filed 9 Feb 2026.